全球金黄杆菌属菌株的抗菌药敏性及流行病学：哨兵抗菌监测计划（1997 - 2001年）报告
Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001).
作者信息
Kirby Jeffrey T, Sader Helio S, Walsh Timothy R, Jones Ronald N
机构信息
The Jones Group/JMI Laboratories, North Liberty, Iowa, USA.
出版信息
J Clin Microbiol. 2004 Jan;42(1):445-8. doi: 10.1128/JCM.42.1.445-448.2004.
Abstract
Limited data are available on Chryseobacterium spp. leading to an evaluation of the patient demographics and susceptibility patterns for Chryseobacterium spp. collected in the first 5 years of the SENTRY Antimicrobial Surveillance Program (1997 to 2001). Fifty isolates (24 Chryseobacterium meningosepticum, 20 Chryseobacterium indologenes, two Chryseobacterium gleum, and 4 Chryseobacterium spp. isolates) were collected. The highest Chryseobacterium prevalence was detected among the elderly. The most active antimicrobials were the newer quinolones (garenoxacin, gatifloxacin, and levofloxacin, each with a MIC at which 90 percent of the isolates are inhibited [MIC(90)] of 1 micro g/ml and 98.0% susceptibility) followed by rifampin (MIC(90), 2 microg/ml and 85.7% susceptibility). Trimethoprim-sulfamethoxazole, ciprofloxacin, and piperacillin-tazobactam also showed reasonable activity; vancomycin showed poor potency.
摘要
关于金黄杆菌属的数据有限，这促使我们对哨兵抗菌监测计划（1997年至2001年）头5年收集的金黄杆菌属患者人口统计学特征和药敏模式进行评估。共收集了50株菌株（24株脑膜炎败血金黄杆菌、20株产吲哚金黄杆菌、2株黏金黄杆菌和4株未明确的金黄杆菌属菌株）。在老年人中检测到金黄杆菌属的患病率最高。活性最强的抗菌药物是新型喹诺酮类（加替沙星、加替沙星和左氧氟沙星，其对90%分离株的最低抑菌浓度[MIC(90)]均为1μg/ml，药敏率为98.0%），其次是利福平（MIC(90)为2μg/ml，药敏率为85.7%）。甲氧苄啶-磺胺甲恶唑、环丙沙星和哌拉西林-他唑巴坦也显示出合理的活性；万古霉素活性较差。
相似文献
1
Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001).全球金黄杆菌属菌株的抗菌药敏性及流行病学：哨兵抗菌监测计划（1997 - 2001年）报告
J Clin Microbiol. 2004 Jan;42(1):445-8. doi: 10.1128/JCM.42.1.445-448.2004.
2
Differences in Clinical Manifestations, Antimicrobial Susceptibility Patterns, and Mutations of Fluoroquinolone Target Genes between Chryseobacterium gleum and Chryseobacterium indologenes.韧皮杆菌属和产吲哚金黄杆菌属在临床症状、抗菌药物敏感性模式以及氟喹诺酮类药物靶基因突变方面的差异。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.02256-18. Print 2019 May.
3
Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000).加替沙星（BMS284756）对皮肤和软组织感染相关病原体活性的地理差异：SENTRY抗菌监测项目（2000年）报告
Diagn Microbiol Infect Dis. 2002 Aug;43(4):303-9. doi: 10.1016/s0732-8893(02)00415-7.
4
Clinical Strains of Chryseobacterium and Elizabethkingia spp. Isolated from Pediatric Patients in a University Hospital: Performance of MALDI-TOF MS-Based Identification, Antimicrobial Susceptibilities, and Baseline Patient Characteristics.从大学医院儿科患者中分离出的金黄杆菌属和伊丽莎白菌属临床菌株：基于基质辅助激光解吸电离飞行时间质谱（MALDI-TOF MS）的鉴定性能、抗菌药敏性及患者基线特征
Microb Drug Resist. 2018 Jul/Aug;24(6):816-821. doi: 10.1089/mdr.2017.0206. Epub 2017 Dec 11.
5
Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing.金黄杆菌属和黄杆菌属细菌抗菌药物敏感性的重新评估以及可靠药敏试验方法
Antimicrob Agents Chemother. 1997 Dec;41(12):2738-41. doi: 10.1128/AAC.41.12.2738.
6
Comparative activity of garenoxacin (BMS 284756), a novel desfluoroquinolone, tested against 8,331 isolates from community-acquired respiratory tract infections: North American results from the SENTRY Antimicrobial Surveillance Program (1999-2001).新型去氟喹诺酮类药物加替沙星（BMS 284756）对8331株社区获得性呼吸道感染分离菌株的比较活性：哨兵抗菌监测计划（1999 - 2001年）的北美结果
Diagn Microbiol Infect Dis. 2003 Apr;45(4):273-8. doi: 10.1016/s0732-8893(03)00002-6.
7
[Comparative in vitro activity of garenoxacin (BMS-284756). Sentry program, Spain (1999-2000)].[加替沙星（BMS-284756）的体外活性比较。西班牙哨兵计划（1999 - 2000年）]
Enferm Infecc Microbiol Clin. 2003 Oct;21(8):404-9. doi: 10.1016/s0213-005x(03)72977-2.
8
Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997-99).环丙沙星或左氧氟沙星的抗菌药敏试验结果能否预测对新型氟喹诺酮类药物加替沙星的敏感性？：来自哨兵抗菌监测计划（1997 - 1999年）的报告
Diagn Microbiol Infect Dis. 2001 Apr;39(4):237-43. doi: 10.1016/s0732-8893(01)00229-2.
9
Clinical and epidemiological features of Chryseobacterium indologenes infections: analysis of 215 cases.阴沟肠杆菌感染的临床和流行病学特征：215 例分析。
J Microbiol Immunol Infect. 2013 Dec;46(6):425-32. doi: 10.1016/j.jmii.2012.08.007. Epub 2012 Sep 27.
10
Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).对在北美和拉丁美洲分离出的对超广谱头孢菌素和氟喹诺酮耐药的沙门氏菌属的分析：哨兵抗菌监测计划（1997 - 2004年）报告
Diagn Microbiol Infect Dis. 2006 Jan;54(1):13-21. doi: 10.1016/j.diagmicrobio.2005.06.013. Epub 2005 Nov 14.
引用本文的文献
1
Elizabethkingia meningoseptica With Targeted Environmental Surveillance in a Tertiary Care Hospital: A Retrospective Cohort Study.三级护理医院中针对脑膜败血伊丽莎白金菌的环境监测：一项回顾性队列研究
Cureus. 2025 Jul 1;17(7):e87095. doi: 10.7759/cureus.87095. eCollection 2025 Jul.
2
Clinical and Epidemiological Features and Antimicrobial Susceptibility Patterns of Species: A Scoping Review.物种的临床和流行病学特征及抗菌药物敏感性模式：一项范围综述
Medicina (Kaunas). 2025 Jun 30;61(7):1197. doi: 10.3390/medicina61071197.
3
From wastewater to resistance: characterization of multidrug-resistant bacteria and assessment of natural antimicrobial compounds.从废水到耐药性：多重耐药菌的特性及天然抗菌化合物的评估
Front Microbiol. 2025 Jul 10;16:1612534. doi: 10.3389/fmicb.2025.1612534. eCollection 2025.
4
Unraveling the global landscape of Elizabethkingia antibiotic resistance: A systematic review and meta-analysis.解析伊丽莎白菌属抗生素耐药性的全球格局：一项系统综述和荟萃分析。
PLoS One. 2025 May 30;20(5):e0323313. doi: 10.1371/journal.pone.0323313. eCollection 2025.
5
A case of hospital-acquired pneumonia associated with Chryseobacterium indologenes infection in a patient with HIV infection and review of the literature.1例HIV感染患者发生与产吲哚金黄杆菌感染相关的医院获得性肺炎及文献复习
AIDS Res Ther. 2025 May 23;22(1):53. doi: 10.1186/s12981-025-00749-1.
6
Genome sequence of , isolated from a red-backed salamander () in Rugar Woods, NY, USA.从美国纽约鲁加伍兹的一只红背蝾螈（Plethodon cinereus）分离得到的……的基因组序列。 （注：原文中“Genome sequence of ”后面缺少具体内容）
Microbiol Resour Announc. 2025 May 8;14(5):e0012425. doi: 10.1128/mra.00124-25. Epub 2025 Apr 15.
7
Rare or Unusual Non-Fermenting Gram-Negative Bacteria: Therapeutic Approach and Antibiotic Treatment Options.罕见或不常见的非发酵革兰氏阴性菌：治疗方法与抗生素治疗选择
Antibiotics (Basel). 2025 Mar 16;14(3):306. doi: 10.3390/antibiotics14030306.
8
Screening and genomic evaluation of keratinolytic protease producing Chryseobacterium sp. from tannery waste and its potential application in dehairing of goat skin.从制革废料中筛选产角蛋白酶的 Chryseobacterium sp. 并进行基因组评估及其在山羊皮脱毛中的潜在应用
J Genet Eng Biotechnol. 2025 Mar;23(1):100458. doi: 10.1016/j.jgeb.2025.100458. Epub 2025 Jan 19.
9
Clinical presentation and outcomes of bloodstream infection with intrinsically carbapenem-resistant non-fermenting gram-negative organisms: Stenotrophomonas maltophilia, Elizabethkingia spp. and Chryseobacterium spp. in Singapore, from 2012 to 2024.2012年至2024年新加坡耐碳青霉烯类非发酵革兰阴性菌血流感染的临床表现及结局：嗜麦芽窄食单胞菌、伊丽莎白菌属和金黄杆菌属
BMC Infect Dis. 2025 Feb 25;25(1):273. doi: 10.1186/s12879-025-10636-9.
10
Analyzing the Interaction between and Bacteria under Different Physicochemical Conditions When Infecting Guppy Using the eDNA Method.使用环境DNA方法分析在不同理化条件下感染孔雀鱼时[具体对象]与细菌之间的相互作用。 （注：原文中“Analyzing the Interaction between and Bacteria”里“between”后缺少具体内容）
Animals (Basel). 2024 Jul 27;14(15):2194. doi: 10.3390/ani14152194.
本文引用的文献
1
Analysis of an outbreak due to Chryseobacterium meningosepticum in a neonatal intensive care unit.新生儿重症监护病房中脑膜脓毒性金黄杆菌引起的一次暴发分析。
New Microbiol. 2003 Jan;26(1):57-63.
2
Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS284756 (T-3811) tested against non-fermentative Gram-negative bacilli.
Clin Microbiol Infect. 2002 Jun;8(6):340-4. doi: 10.1046/j.1469-0691.2002.00399.x.
3
Molecular and biochemical characterization of Ambler class A extended-spectrum beta-lactamase CGA-1 from Chryseobacterium gleum.来自黏金黄杆菌的安布勒A类超广谱β-内酰胺酶CGA-1的分子和生化特征
Antimicrob Agents Chemother. 2002 Apr;46(4):966-70. doi: 10.1128/AAC.46.4.966-970.2002.
4
Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device.一名植入完全植入式血管内装置的肿瘤患者发生产吲哚金黄杆菌复发性菌血症。
Clin Microbiol Infect. 2001 Jul;7(7):391-3. doi: 10.1046/j.1198-743x.2001.00273.x.
5
Chryseobacterium (Flavobacterium) meningosepticum outbreak associated with colonization of water taps in a neonatal intensive care unit.与新生儿重症监护病房水龙头定植相关的脑膜败血金黄杆菌（黄杆菌属）暴发。
J Hosp Infect. 2001 Mar;47(3):188-92. doi: 10.1053/jhin.2000.0908.
6
Chryseobacterium in burn wounds.
Burns. 2001 Mar;27(2):179-82. doi: 10.1016/s0305-4179(00)00087-5.
7
Plasmid location and molecular heterogeneity of the L1 and L2 beta-lactamase genes of Stenotrophomonas maltophilia.嗜麦芽窄食单胞菌L1和L2β-内酰胺酶基因的质粒定位及分子异质性
Antimicrob Agents Chemother. 2001 Feb;45(2):413-9. doi: 10.1128/AAC.45.2.413-419.2001.
8
Genetic diversity of carbapenem-hydrolyzing metallo-beta-lactamases from Chryseobacterium (Flavobacterium) indologenes.产吲哚金黄杆菌（黄杆菌属）中碳青霉烯水解金属β-内酰胺酶的遗传多样性
Antimicrob Agents Chemother. 2000 Nov;44(11):3028-34. doi: 10.1128/AAC.44.11.3028-3034.2000.
9
Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing beta-lactamases in Chryseobacterium meningosepticum.脑膜炎败血金黄杆菌中B类碳青霉烯水解β-内酰胺酶的分子和生化异质性
Antimicrob Agents Chemother. 2000 Jul;44(7):1878-86. doi: 10.1128/AAC.44.7.1878-1886.2000.
10
Cloning of a Chryseobacterium (Flavobacterium) meningosepticum chromosomal gene (blaA(CME)) encoding an extended-spectrum class A beta-lactamase related to the Bacteroides cephalosporinases and the VEB-1 and PER beta-lactamases.克隆与拟杆菌属头孢菌素酶、VEB-1和PERβ-内酰胺酶相关的产超广谱A类β-内酰胺酶的脑膜炎败血金黄杆菌（黄杆菌属）染色体基因（blaA(CME)）。
Antimicrob Agents Chemother. 1999 Sep;43(9):2193-9. doi: 10.1128/AAC.43.9.2193.
Zotero 插件